Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

27

Other

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

27

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1921

27

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Fatigue

27

Hyperphosphatemia

27

Hypophosphatemia

27

Lose body protein

27

Nausea

27

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Diagnostic

27

Palliative

27

Primary

27

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

25

Mixture

3

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

28

CAS

27

EPA CompTox

26

PUBCHEM

25

SMS_ID

22

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

1

BLOOD AND BLOOD FORMING ORGANS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS

1

LAXATIVES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

I.V. SOLUTION ADDITIVES

1

LAXATIVES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Electrolyte solutions

1

Enemas

1

Osmotically acting laxatives

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

26

Principal Form

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 28 results

First page disabled
Previous page disabled
1
Next page
Next page

Phosphate ion

NK08V8K8HR

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

1-NONANAMINE

7L7H2HT4OK

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Phosphoric Acid

E4GA8884NN

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

AMMONIUM SODIUM PHOSPHATE TETRAHYDRATE

K78U8WLV4H

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

PHOSPHATE ION(2-)

33UE6C4909

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

AMMONIUM PHOSPHATE, TRIBASIC

2ZJF06M0I9

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

AMMONIUM SODIUM PHOSPHATE

SWP615T2VF

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

MONOBASIC POTASSIUM PHOSPHATE

4J9FJ0HL51

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

SODIUM PHOSPHATE, TRIBASIC, DODECAHYDRATE

B70850QPHR

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

SODIUM PHOSPHATE, DIBASIC, MONOHYDRATE

BWZ7K44R51

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

Showing 1 - 10 of 28 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1